BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28621677)

  • 1. Genome-wide methylome and chromatin interactome identify abnormal enhancer to be risk factor of breast cancer.
    Wang Y; Hao DP; Li JJ; Wang L; Di LJ
    Oncotarget; 2017 Jul; 8(27):44705-44719. PubMed ID: 28621677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
    Aure MR; Fleischer T; Bjørklund S; Ankill J; Castro-Mondragon JA; ; Børresen-Dale AL; Tost J; Sahlberg KK; Mathelier A; Tekpli X; Kristensen VN
    Genome Med; 2021 Apr; 13(1):72. PubMed ID: 33926515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients.
    Park SM; Choi EY; Bae M; Choi JK; Kim YJ
    Clin Epigenetics; 2017; 9():73. PubMed ID: 28748001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer.
    Cho JW; Hong MH; Ha SJ; Kim YJ; Cho BC; Lee I; Kim HR
    Exp Mol Med; 2020 Sep; 52(9):1550-1563. PubMed ID: 32879421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
    Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
    Craig JM; Turner TH; Harrell JC; Clevenger CV
    Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
    Liu X; Peng Y; Wang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation at enhancers identifies distinct breast cancer lineages.
    Fleischer T; Tekpli X; Mathelier A; Wang S; Nebdal D; Dhakal HP; Sahlberg KK; Schlichting E; ; Børresen-Dale AL; Borgen E; Naume B; Eskeland R; Frigessi A; Tost J; Hurtado A; Kristensen VN
    Nat Commun; 2017 Nov; 8(1):1379. PubMed ID: 29123100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women.
    Song MA; Brasky TM; Marian C; Weng DY; Taslim C; Dumitrescu RG; Llanos AA; Freudenheim JL; Shields PG
    Epigenetics; 2015; 10(12):1177-87. PubMed ID: 26680018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer.
    Rhee JK; Kim K; Chae H; Evans J; Yan P; Zhang BT; Gray J; Spellman P; Huang TH; Nephew KP; Kim S
    Nucleic Acids Res; 2013 Oct; 41(18):8464-74. PubMed ID: 23887935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer.
    Kulak MV; Cyr AR; Woodfield GW; Bogachek M; Spanheimer PM; Li T; Price DH; Domann FE; Weigel RJ
    Oncogene; 2013 Aug; 32(34):4043-51. PubMed ID: 22964634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis.
    Kim B; Kang S; Jeong G; Park SB; Kim SJ
    PLoS One; 2014; 9(5):e97818. PubMed ID: 24842468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of aberrant methylation of enhancer DNA in human osteoarthritis.
    Lin X; Li L; Liu X; Tian J; Zheng W; Li J; Wang L
    BMC Med Genomics; 2020 Jan; 13(1):1. PubMed ID: 31900157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.
    Wen W; Chen Z; Bao J; Long Q; Shu XO; Zheng W; Guo X
    Nat Commun; 2021 Sep; 12(1):5318. PubMed ID: 34518541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stilbenoids remodel the DNA methylation patterns in breast cancer cells and inhibit oncogenic NOTCH signaling through epigenetic regulation of MAML2 transcriptional activity.
    Lubecka K; Kurzava L; Flower K; Buvala H; Zhang H; Teegarden D; Camarillo I; Suderman M; Kuang S; Andrisani O; Flanagan JM; Stefanska B
    Carcinogenesis; 2016 Jul; 37(7):656-68. PubMed ID: 27207652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.